Corson TW - Search Results

1

The genomic landscape of retinoblastoma: a review.

Thériault BL, Dimaras H, Gallie BL, Corson TW. Thériault BL, et al. Among authors: corson tw. Clin Exp Ophthalmol. 2014 Jan-Feb;42(1):33-52. doi: 10.1111/ceo.12132. Epub 2013 May 22. Clin Exp Ophthalmol. 2014. PMID: 24433356 Free PMC article. Review.

2

Identification of Novel Pathways Regulated by APE1/Ref-1 in Human Retinal Endothelial Cells.

Mijit M, Liu S, Sishtla K, Hartman GD, Wan J, Corson TW, Kelley MR. Mijit M, et al. Among authors: corson tw. Int J Mol Sci. 2023 Jan 6;24(2):1101. doi: 10.3390/ijms24021101. Int J Mol Sci. 2023. PMID: 36674619 Free PMC article.

3

Mouse Pharmacokinetics and In Vitro Metabolism of SH-11037 and SH-11008, Synthetic Homoisoflavonoids for Retinal Neovascularization.

Kim EY, Lee B, Kwon S, Corson TW, Seo SY, Lee K. Kim EY, et al. Among authors: corson tw. Pharmaceutics. 2022 Oct 24;14(11):2270. doi: 10.3390/pharmaceutics14112270. Pharmaceutics. 2022. PMID: 36365089 Free PMC article.

4

Antiangiogenic Pterocarpan and Flavonoid Constituents of Erythrina lysistemon.

Nassief SM, Amer ME, Shawky E, Sishtla K, Mas-Claret E, Muniyandi A, Corson TW, Mulholland DA, El-Masry S. Nassief SM, et al. Among authors: corson tw. J Nat Prod. 2023 Apr 28;86(4):759-766. doi: 10.1021/acs.jnatprod.2c00909. Epub 2023 Mar 20. J Nat Prod. 2023. PMID: 36938984

5

Decreased Expression of Soluble Epoxide Hydrolase Suppresses Murine Choroidal Neovascularization.

Park B, Sardar Pasha SPB, Sishtla KL, Hartman GD, Qi X, Boulton ME, Corson TW. Park B, et al. Among authors: corson tw. Int J Mol Sci. 2022 Dec 9;23(24):15595. doi: 10.3390/ijms232415595. Int J Mol Sci. 2022. PMID: 36555236 Free PMC article.

6

Beyond VEGF: Targeting Inflammation and Other Pathways for Treatment of Retinal Disease.

Muniyandi A, Hartman GD, Song Y, Mijit M, Kelley MR, Corson TW. Muniyandi A, et al. Among authors: corson tw. J Pharmacol Exp Ther. 2023 Jul;386(1):15-25. doi: 10.1124/jpet.122.001563. Epub 2023 May 4. J Pharmacol Exp Ther. 2023. PMID: 37142441 Free PMC article. Review.

7

PRMT5 is a therapeutic target in choroidal neovascularization.

Muniyandi A, Martin M, Sishtla K, Motolani A, Sun M, Jensen NR, Qi X, Boulton ME, Prabhu L, Lu T, Corson TW. Muniyandi A, et al. Among authors: corson tw. Sci Rep. 2023 Jan 31;13(1):1747. doi: 10.1038/s41598-023-28215-w. Sci Rep. 2023. PMID: 36720900 Free PMC article.

8

Synthesis and Structure Revision of Naturally Occurring Homoisoflavane (+)-Dracaeconolide B.

Kwon S, Lee S, Hur J, Ko K, Fei X, Jeong KW, Sishtla K, Muniyandi A, Bae M, Corson TW, Seo SY. Kwon S, et al. Among authors: corson tw. J Nat Prod. 2023 Jan 27;86(1):149-156. doi: 10.1021/acs.jnatprod.2c00859. Epub 2022 Dec 21. J Nat Prod. 2023. PMID: 36542352

9

Minimal 16q genomic loss implicates cadherin-11 in retinoblastoma.

Marchong MN, Chen D, Corson TW, Lee C, Harmandayan M, Bowles E, Chen N, Gallie BL. Marchong MN, et al. Among authors: corson tw. Mol Cancer Res. 2004 Sep;2(9):495-503. Mol Cancer Res. 2004. PMID: 15383628

10

KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers.

Corson TW, Huang A, Tsao MS, Gallie BL. Corson TW, et al. Oncogene. 2005 Jul 14;24(30):4741-53. doi: 10.1038/sj.onc.1208641. Oncogene. 2005. PMID: 15897902

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

88 results

Search Page